Multiple sclerosis and Depression
Summary:
Depression is found among people with Multiple sclerosis, especially for people who are female, 50-59 old.
The study analyzes which people have Depression with Multiple sclerosis. It is created by eHealthMe based on reports of 20,384 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
20,384 people who have Multiple Sclerosis and Depression are studied.
What is Multiple sclerosis?
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 2,187 drugs and 1,319 conditions by eHealthMe.
What is Depression?
Depression is found to be associated with 4,173 drugs and 4,010 conditions by eHealthMe.
Number of Depression in Multiple sclerosis reports submitted per year:
Gender of people who have Multiple sclerosis and experienced Depression *:
Age of people who have Multiple sclerosis and experienced Depression *:
Common co-existing conditions for these people *:
Common drugs taken by these people *:
Common symptoms for these people *:
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Depression?
Check whether Depression is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
Related studies
Treatments, associated drugs and conditions:
- Multiple sclerosis (734,949 reports)
- Depression (598,782 reports)
COVID vaccines that are related to Depression:
- Depression in Moderna COVID Vaccine
- Depression in Pfizer BioNTech Covid Vaccine
- Depression in Johnson and Johnson Covid Vaccine
Common drugs associated with Depression:
- Chantix: 11,911 reports
- Accutane: 9,826 reports
- Oxycontin: 9,692 reports
- Prednisone: 9,619 reports
- Aspirin: 9,458 reports
- Zoloft: 8,834 reports
- Fosamax: 8,381 reports
- Vioxx: 7,964 reports
- Gabapentin: 7,920 reports
- Cymbalta: 7,851 reports
All the drugs that are associated with Depression:
- Depression (4,173 drugs)
Common conditions associated with Depression:
- Multiple sclerosis: 20,384 reports
- Pain: 12,961 reports
- High blood pressure: 10,315 reports
- Rheumatoid arthritis: 10,067 reports
- Stress and anxiety: 9,456 reports
All the conditions that are associated with Depression:
- Depression (4,010 conditions)
How the study uses the data?
The study is based on Depression and Multiple sclerosis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Theovent and Gemcitabine Hydrochloride drug interaction - now
- Loraz and Requip Xl drug interaction - now
- Stroke and Subcutaneous Haematoma - 4 seconds ago
- Stroke and Haemorrhagic Diathesis - 8 seconds ago
- Ritonavir and Lymphocyte Count Increased - 9 seconds ago
- How effective is Dilantin for Generalized Tonic-Clonic Seizure? - 9 seconds ago
- Type 2 Diabetes and Spondylolysis - 11 seconds ago
- Celexa and Darvon Compound drug interaction - 12 seconds ago
- Type 2 Diabetes and Smell - Impaired - 12 seconds ago
- Megace and Dyspnea Paroxysmal Nocturnal - 13 seconds ago